3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Standard of Care
18
Gemcitabine
18
Radiosurgery
14
Drug Therapy
13
Blood Specimen Collection
13
Endoscopic Ultrasound-Guided Fine Needle Aspiration
11
Exercise
10
Pancreaticoduodenectomy
9
Practice Guidelines as Topic
8
Methods
8
Magnetic Resonance Spectroscopy
8
Biopsy, Fine-Needle
8
Capecitabine
7
Early Intervention, Educational
6
Biopsy
6
Surveys and Questionnaires
5
Stents
5
Specimen Handling
5
Resistance Training
5
Radiofrequency Ablation
5
Psychiatric Rehabilitation
5
Oxaliplatin
5
Fluorouracil
5
Cholangiopancreatography, Endoscopic Retrograde
5
130-nm albumin-bound paclitaxel
5
Secretin
4
Radiotherapy
4
Irinotecan
4
Heavy Ion Radiotherapy
4
Electroporation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pancreatic Neoplasms
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled